1.PRIMARY CULTURE OF HUMAN FETAL ADRENAL MEDULLARY CELLS
Dansha HE ; Weiyi DENG ; Yuanhao LI ; Qingrong ZENG ; Jing YIE
Acta Anatomica Sinica 1957;0(04):-
A simple method for culture of human fetal adrenal medullary cells is described. Enzymatically dissociated human fetal adrenal cells were isolaled by centrifugation on Percoll in the buffer. Adrenal medullary cells with 75%-85% purity were obtained by this procedure. The medullary cells were then plated on plastic culture dishes coated with collagen. After 2-7 days medullary Cells began to flatten and extended processes. A further identification of the cells as medullary in origin was confirmed, by specific catecholamine fluorescence technique. Catecholamine content in the medium was also determined by HPLC.
2.Study on gene delivery via the bile duct to rat liver using naked DNA particles.
Jin-hua HU ; Biao XU ; Jing CHEN ; Wei-ping HE ; Yie-dong WANG ; Hui-fen WANG
Chinese Journal of Hepatology 2010;18(2):140-143
OBJECTIVETo evaluate the efficacy of gene delivery to the right lateral lobe of the rat liver via a branch of the bile duct using naked DNA.
METHODSWe evaluated regional gene delivery to the right lateral lobe of the rat liver via a branch of the bile duct, using naked DNA, including pGL3, pCMV beta and Cy3 labeled CMV beta.
RESULTSGene expression was observed in right lateral lobe of both the damaged and the normal rats liver. The gene delivery efficiency was similar in two groups (P > 0.05). Gene expression was found in the right lateral lobe of damaged and normal livers. Fluorescence was observed in the region of the portal triads, and occasionally, in the lobule.
CONCLUSIONRetrograde infusion of naked DNA via the bile duct is an effective way to deliver genes to in both damaged and normal rat liver.
Animals ; Bile Ducts ; metabolism ; DNA ; genetics ; Disease Models, Animal ; Female ; Galactose ; Gene Expression ; Gene Transfer Techniques ; Genes, Reporter ; Genetic Therapy ; methods ; Genetic Vectors ; Liver ; metabolism ; pathology ; Liver Diseases ; genetics ; pathology ; therapy ; Luciferases ; genetics ; metabolism ; Plasmids ; genetics ; Rats ; Rats, Inbred Lew ; beta-Galactosidase ; genetics ; metabolism
3.Prospective randomized trial of RFA and chemotherapy for unresectable small hepatocellular carcinoma.
Yu-Hong GAN ; Sheng-Long YIE ; Zheng-Gang REN ; Jing-Lin XIA ; Bo-Heng ZHANG ; Yan-Hong WANG ; Ning-Ling GE ; Yi CHEN ; Bi-Wei YANG
Chinese Journal of Oncology 2004;26(8):496-498
OBJECTIVETo study the clinical safety and effect on local recurrence in unresectable small hepatocellular carcinoma treated by radiofrequency ablation (RFA) with and without chemotherapy through a prospective randomized trial.
METHODSThirty-eight unresectable small hepatocellular carcinoma patients with diameter = 3 cm were selected, of which 27 patients have been followed up for 1 year. Through a prospective randomized trial, 12 patients were in the RFA group and 15 patients in the RFA combined with systemic chemotherapy group. RFA was given image-guided. The regimen of systemic chemotherapy: EADM 50 mg on day 1, 3; CDDP 40 mg on day 1, 3 and FUDR 500 mg on day 1, 2, 3. After RFA treatment, liver function, WBC count and complications were observed on day 1, 4, 7; CT scan was performed in 1, 6, 12 months. The safety and local recurrence were analyzed.
RESULTSThere was no local recurrence of the tumor in the two groups 1 month after RFA treatment. The 6- and 12-month local recurrence rates were significantly lower in the combined group than that in RFA group alone (P < 0.01). There were no severe complications in the two groups, and nor was there any significant difference in liver function and WBC count.
CONCLUSIONRFA combined with systemic chemotherapy is safe, and it can reduce the local recurrence of unresectable small hepatocellular carcinoma = 3 cm in diameter.
Antineoplastic Combined Chemotherapy Protocols ; therapeutic use ; Carcinoma, Hepatocellular ; drug therapy ; therapy ; Catheter Ablation ; Cisplatin ; administration & dosage ; Combined Modality Therapy ; Epirubicin ; administration & dosage ; Female ; Fluorouracil ; administration & dosage ; Follow-Up Studies ; Humans ; Liver Neoplasms ; drug therapy ; therapy ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Prospective Studies ; Ultrasonography, Interventional